APA (7th ed.) Citation

Hüser, L., Kokkaleniou, M., Granados, K., Dworacek, J., Federico, A., Vierthaler, M., . . . Utikal, J. (2020). HER3-receptor-mediated STAT3 activation plays a central role in adaptive resistance toward vemurafenib in melanoma. Cancers, 12(12), . https://doi.org/10.3390/cancers12123761

Chicago Style (17th ed.) Citation

Hüser, Laura, et al. "HER3-receptor-mediated STAT3 Activation Plays a Central Role in Adaptive Resistance Toward Vemurafenib in Melanoma." Cancers 12, no. 12 (2020). https://doi.org/10.3390/cancers12123761.

MLA (9th ed.) Citation

Hüser, Laura, et al. "HER3-receptor-mediated STAT3 Activation Plays a Central Role in Adaptive Resistance Toward Vemurafenib in Melanoma." Cancers, vol. 12, no. 12, 2020, https://doi.org/10.3390/cancers12123761.